Who can be considered for evaluation?
An evaluation can be performed for people who have difficulty losing weight, have an increased waist circumference, have insulin resistance or metabolic risks, or want to maintain their weight loss. The goal is not only weight loss but also preserving muscle mass and long-term metabolic health.
How is it planned?
Body composition, waist circumference, glucose-insulin markers, lipids, liver health, sleep, muscle strength, nutrition, and movement are evaluated together. Lifestyle, medication treatments if needed, and supportive measures are personalized within the same plan.
Weight management and metabolic health showcase
You can directly access evaluation and treatment options by selecting your reason for seeking care or your area of interest.
Causes, risks, and treatment optionsInsulin Resistance
Glucose, HbA1c, TG/HDL, and metabolic syndromePreventing Muscle Loss
Sarcopenia, protein, and resistance exerciseSleep and Weight
Sleep apnea, appetite, and metabolic healthLongevity
Connect weight management to a healthy aging planMetabolic Support IV
An IV approach based on deficiency and clinical need
Treatment approach
Sustainable energy balance, adequate protein and fiber
Resistance exercise, aerobic capacity, and daily movement
Sleep, stress, appetite, and eating behavior
GLP-1/GIP and other medical options for appropriate individuals
Monitoring waist circumference, muscle mass, and fat distribution
Multidisciplinary evaluation in selected individuals
What is examined during the initial evaluation?
- Weight history and previous diet/medication experiences
- BMI, waist circumference, and body composition
- Muscle mass and muscle strength
- Blood pressure and cardiovascular risk
- Fasting glucose, HbA1c, and insulin resistance markers when necessary
- Lipid profile; triglycerides, HDL, LDL, and the HDL/TG ratio in the clinical context
- Risk of fatty liver/MASLD
- Sleep quality and the possibility of sleep apnea
- Thyroid, menopause, testosterone, and other conditions that may affect weight gain
- Medications and eating behavior that may contribute to weight gain
Medications in weight management
Obesity pharmacotherapy can be an effective treatment step added to lifestyle modifications for appropriate individuals. GLP-1 receptor agonists and medications with GIP/GLP-1 activity can provide significant weight loss. When selecting a medication, diabetes, cardiovascular disease, kidney and liver status, gallbladder history, gastrointestinal tolerance, other medications being used, pregnancy plans, and personal goals are evaluated together.
During medication treatment, adequate protein, resistance exercise, fluid intake, gastrointestinal tolerance, and muscle mass are monitored. Because appetite and weight may increase again in some individuals when treatment is discontinued, the maintenance phase is planned separately.
CGM and metabolic measurements
Continuous glucose monitoring is an important clinical tool for people with diabetes. In selected situations, it may also help people without diabetes understand the relationship between meals, activity, and glucose response. Rather than interpreting individual glucose spikes as disease, the overall trend, clinical goal, and laboratory data are evaluated together.
Our approach at our Bodrum clinic
The initial goal is not the fastest possible weight loss, but to identify the factors contributing to the person’s weight gain and their priority health risks. Body composition, waist circumference, muscle strength, sleep, nutrition, movement, medications used, and laboratory markers are evaluated together.
We monitor the success of the plan through muscle mass, waist circumference, glucose-insulin balance, lipid profile, physical capacity, and sustainability, in addition to kilograms. If there are coexisting conditions that may affect weight management, such as menopause, low testosterone, sleep apnea, or chronic pain, we address these within the same clinical framework as well.
Related content
- Functional medicine
- Healthy aging and Longevity
- Testosterone and men’s health
- Menopause and metabolic health
References
- World Health Organization. Obesity and overweight. Updated: 8 December 2025. WHO
- American Diabetes Association Professional Practice Committee for Obesity. Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity. 2026. DOI
Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: 10 September 2026
Image note: The page image is a representative clinical image generated with artificial intelligence.
Disclaimer: This content is intended for general medical information; it does not replace individual diagnosis or treatment recommendations.
Clinical evaluation in Bodrum: you can use the Bodrum Clinic and Appointments and Contact pages to discuss whether the intervention is appropriate for you.